JSW Infrastructure Limited vs Sheel Biotech Limited
A side-by-side comparison of JSW Infrastructure Limited (JSWINFRA) and Sheel Biotech Limited (SHEEL) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, JSW Infrastructure Limited leads JSWINFRA vs SHEEL on 11 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation22
- Profitability40
- Growth20
- Size & financial health31
Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.
Valuation
EvenHow expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
JSWINFRA takes 4/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
JSWINFRA takes 2/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
JSWINFRA takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company has delivered good profit growth of 40.3% CAGR over last 5 years", "Company has delivered good sales growth of 27.3% CAGR over last 5 years"]
- − ["Stock is trading at 7.29 times its book value"]
- + ["Company has delivered good profit growth of 18.7% CAGR over last 5 years", "Company is almost debt free."]
- − []
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.